Novartis AG Common Stock (NVS)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
NVS Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
NVS Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
NVS deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 127,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 97,999,807 | |
| 0 | |
| 0 | |
| 0 | |
| 123,000,297 | |
| 0 | |
| 0 | |
| 0 | |
| 123,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 56,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 113,999,507 | |
| 15,244,000,000 | |
| 17,158,000,000 | |
| 38,684,000,000 | |
| 236,000,000 | |
| 14,104,000,000 | |
| 0 | |
| 0 | |
| 305,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 287,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 385,000,000 | |
| 0 | |
| 14,068,000,000 | |
| 13,487,000,000 | |
| 329,000,000 | |
| 12,587,000,000 | |
| 12,786,000,000 | |
| 0 | |
| 70,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 71,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 70,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 79,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 90,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 88,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 91,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 77,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 74,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 13,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 14,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 14,000,000 | |
| 0 | |
| 0 | |
| 158,000,000 | |
| 0 | |
| 0 |